Objective:To explore the clinical application value of press-needle assisted sedation therapy in sedation treatment of intensive care unit (ICU) under bispectral index (BIS) monitoring.Methods:A total of 30 critically ill patients admitted to the ICU of the China-Japan Friendship Hospital from July 2024 to January 2025 were selected. A prospective self before-after control method was used. On the basis of conventional analgesic and sedative drug treatment, traditional Chinese medicine press-needles were combined to stimulate the head emotion area, Yintang (GV29), Hegu (LI4), Neiguan (PC6), and Zusanli (ST36). The BIS, dosages of remifentanil and propofol, respiratory and circulatory functions, and lactate levels before and after treatment were compared.Results:The BIS value dropped to stability (21.90±13.67)min after press-needle treatment, with a decrease of (5.73±1.42) ( P<0.05). The dosage of propofol within 8 h after press-needle treatment was reduced by (1.08±0.33)mg/kg compared with that before treatment ( P<0.05). There were no significant differences in heart rate, blood pressure, oxygenation index, and lactate level before and after treatment (all P>0.05). Conclusions:Press-needle assisted sedation therapy can improve the sedative effect, reduce the dosage of propofol sedatives, and has good safety.

Objective:To explore the clinical application value of press-needle assisted sedation therapy in sedation treatment of intensive care unit (ICU) under bispectral index (BIS) monitoring.Methods:A total of 30 critically ill patients admitted to the ICU of the China-Japan Friendship Hospital from July 2024 to January 2025 were selected. A prospective self before-after control method was used. On the basis of conventional analgesic and sedative drug treatment, traditional Chinese medicine press-needles were combined to stimulate the head emotion area, Yintang (GV29), Hegu (LI4), Neiguan (PC6), and Zusanli (ST36). The BIS, dosages of remifentanil and propofol, respiratory and circulatory functions, and lactate levels before and after treatment were compared.Results:The BIS value dropped to stability (21.90±13.67)min after press-needle treatment, with a decrease of (5.73±1.42) ( P<0.05). The dosage of propofol within 8 h after press-needle treatment was reduced by (1.08±0.33)mg/kg compared with that before treatment ( P<0.05). There were no significant differences in heart rate, blood pressure, oxygenation index, and lactate level before and after treatment (all P>0.05). Conclusions:Press-needle assisted sedation therapy can improve the sedative effect, reduce the dosage of propofol sedatives, and has good safety.

OBJECTIVETo evaluate the effectiveness of a helium-oxygen mixture (79%He- 21%O(2)) as an aerosolizing compressed gas for beta(2)-agonist therapy in patients with an asthma exacerbation.

METHODSTwenty-four patients in the outpatient department with a mild to moderate exacerbation of asthma were enrolled. The patients were randomly divided into an experimental group (13 cases) and a control group (11 cases). The experimental group inhaled Berotec with heliox-driven, and the control group inhaled Berotec with compressed air-driven. Eight hospitalized patients in the respiratory department with severe exacerbation of asthma were enrolled. The patients inhaled Berotec with heliox-driven or compressed air-driven in a random order.

RESULTSThe results of spirometric parameters and arterial blood-gas analysis were measured. In the mild to moderate asthma patients, no statistical differences between the two groups for forced vital capacity (FVC), forced expired volume in one second (FEV(1)), and expiratory flow in 50% forced vital capacity (FEF(50)) were presented. But the severe patients showed significant differences between heliox-driven and compressed air-driven for FVC, FEV(1), FEF(50) and partial pressure of oxygen (PaO(2)).

CONCLUSIONSCompared with the traditional inhalation of beta(2)-agonist therapy using compressed air-driven, the method of inhaling beta(2)-agonist with heliox-driven has more obvious benefits for those suffering from severe asthma. This is likely due to the cooperative effects between inhaling heliox on its physical gas properties and improving delivery of beta(2)-agonist in the treatment of exacerbation of severe asthma.

Adrenergic beta-Agonists ; administration & dosage ; Adult ; Asthma ; therapy ; Bronchodilator Agents ; administration & dosage ; Female ; Fenoterol ; administration & dosage ; Helium ; administration & dosage ; Humans ; Male ; Middle Aged ; Oxygen ; administration & dosage